Cargando…
Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933011/ https://www.ncbi.nlm.nih.gov/pubmed/36797421 http://dx.doi.org/10.1038/s41409-023-01936-2 |
| _version_ | 1784889583711813632 |
|---|---|
| author | Capoferri, Gioele Walti, Carla Simone Urwyler, Pascal Ragozzino, Silvio Passweg, Jakob R. Halter, Jörg Battegay, Manuel Baettig, Veronika Weisser, Maja Arnold, Brice Morin, Benedict Guetlin, Yukino Torres, Diana Albertos Barut, Güliz Tuba Thiel, Volker Egli, Adrian Drexler, Beatrice Khanna, Nina |
| author_facet | Capoferri, Gioele Walti, Carla Simone Urwyler, Pascal Ragozzino, Silvio Passweg, Jakob R. Halter, Jörg Battegay, Manuel Baettig, Veronika Weisser, Maja Arnold, Brice Morin, Benedict Guetlin, Yukino Torres, Diana Albertos Barut, Güliz Tuba Thiel, Volker Egli, Adrian Drexler, Beatrice Khanna, Nina |
| author_sort | Capoferri, Gioele |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9933011 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99330112023-02-16 Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation Capoferri, Gioele Walti, Carla Simone Urwyler, Pascal Ragozzino, Silvio Passweg, Jakob R. Halter, Jörg Battegay, Manuel Baettig, Veronika Weisser, Maja Arnold, Brice Morin, Benedict Guetlin, Yukino Torres, Diana Albertos Barut, Güliz Tuba Thiel, Volker Egli, Adrian Drexler, Beatrice Khanna, Nina Bone Marrow Transplant Correspondence Nature Publishing Group UK 2023-02-16 2023 /pmc/articles/PMC9933011/ /pubmed/36797421 http://dx.doi.org/10.1038/s41409-023-01936-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Capoferri, Gioele Walti, Carla Simone Urwyler, Pascal Ragozzino, Silvio Passweg, Jakob R. Halter, Jörg Battegay, Manuel Baettig, Veronika Weisser, Maja Arnold, Brice Morin, Benedict Guetlin, Yukino Torres, Diana Albertos Barut, Güliz Tuba Thiel, Volker Egli, Adrian Drexler, Beatrice Khanna, Nina Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation |
| title | Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation |
| title_full | Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation |
| title_fullStr | Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation |
| title_full_unstemmed | Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation |
| title_short | Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation |
| title_sort | dynamics of antibody titers to sars-cov-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933011/ https://www.ncbi.nlm.nih.gov/pubmed/36797421 http://dx.doi.org/10.1038/s41409-023-01936-2 |
| work_keys_str_mv | AT capoferrigioele dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT walticarlasimone dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT urwylerpascal dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT ragozzinosilvio dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT passwegjakobr dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT halterjorg dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT battegaymanuel dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT baettigveronika dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT weissermaja dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT arnoldbrice dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT morinbenedict dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT guetlinyukino dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT torresdianaalbertos dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT barutguliztuba dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT thielvolker dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT egliadrian dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT drexlerbeatrice dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation AT khannanina dynamicsofantibodytiterstosarscov2andclinicaloutcomesaftersotrovimabpreexposureprophylaxisearlyafterallogeneichematopoieticstemcelltransplantation |